Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 1/2 13Phase 3 12Phase 1 11Phase NA 5Phase 2/3 4

Status

Unknown 4Completed 4Recruiting 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Endocrine 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Pituitary Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Glioblastoma 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Temozolomide × Clear all
NCT03008148 2021-05-11

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Johnpro Biotech, Inc.

Phase 2/3 Unknown
288 enrolled
CNS

Glioblastoma

NCT04244708 2020-01-28

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Peking Union Medical College Hospital

Phase 2/3 Unknown
150 enrolled
Endocrine

Pituitary Neoplasms

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Taizhou Hospital

Phase 2/3 Unknown
400 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

NCT02772107 2016-05-17

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Chinese PLA General Hospital

Phase 2/3 Unknown
132 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡